0

Close
 
Upcoming Allied Market Research
2023
Complex Percutaneous Coronary Intervention Market

Complex Percutaneous Coronary Intervention Market

by Stents (Drug-Eluting Stents (DES), Bare Metal Stents, Bioresorbable Stents) and by Surgery (Percutaneous Coronary Intervention (PCI), Transcatheter Aortic Valve Implantation (TAVI/TAVR), Trans-Mitral Valve Implantation (TMVR)): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A03631
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Complex Percutaneous Coronary Intervention Market

Request Now !

Percutaneous coronary intervention (PCI) is a non-surgical procedure in which a catheter or a stent is used to open narrowed blood vessels which are blocked by deposition of plaque. It is used to improve blood flow and decrease heart-related chest pain improving the patients condition.

Rise in incidences of heart diseases, diabetes, and coronary artery disease, development of advanced stents, and introduction of cost effective intervention devices drive the market for complex percutaneous coronary intervention (PCI). However, low number of heart specialty hospitals and limited availability of heart surgeons restrain the market growth. Moreover, introduction of advanced technologies within the percutaneous coronary intervention such as advanced silicone and polymer implants in the emerging nations such as China, Brazil, and India create opportunities for the market growth during the forecast period.

The complex percutaneous coronary intervention market is segmented on the basis of types of stents, surgery, and region. On the basis of stents, it is divided into drug-eluting stents (DES), bare metal stents, and bioresorbable stents. On the basis of surgery, it is classified into percutaneous coronary intervention (PCI), transcatheter aortic valve implantation (TAVI/TAVR), and trans-mitral valve implantation (TMVR). By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players in the market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B. Braun Melsungen AG, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Terumo Corporation, Johnson & Johnson, Getinge AB, and St. Jude Medical.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis by product helps understand various types of surgeries used for the treatment of coronary intervention.
  • Comprehensive analysis of all geographical regions is provided, which determines the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly, which elucidates the competitive outlook of the global market.

 Complex Percutaneous Coronary Intervention Market Report Highlights

Aspects Details
By Stents
  • Drug-Eluting Stents (DES)
  • Bare Metal Stents
  • Bioresorbable Stents
By Surgery
  • Percutaneous Coronary Intervention (PCI)
  • Transcatheter Aortic Valve Implantation (TAVI/TAVR)
  • Trans-Mitral Valve Implantation (TMVR)
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Boston Scientific Corporation, Abbott Laboratories, B. Braun Melsungen AG, St. Jude Medical., Biosensors International Group, Ltd.,, Johnson & Johnson,, Getinge AB,, Terumo Corporation,, Medtronic plc,, Biotronik SE & Co. KG,
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET, BY STENTS

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Stents

    • 4.2. Drug-Eluting Stents (DES)

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Bare Metal Stents

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Bioresorbable Stents

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET, BY SURGERY

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Surgery

    • 5.2. Percutaneous Coronary Intervention (PCI)

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Transcatheter Aortic Valve Implantation (TAVI/TAVR)

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Trans-Mitral Valve Implantation (TMVR)

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Stents

      • 6.2.3. Market Size and Forecast, By Surgery

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Complex Percutaneous Coronary Intervention Market

        • 6.2.5.1. Market Size and Forecast, By Stents
        • 6.2.5.2. Market Size and Forecast, By Surgery

      • 6.2.6. Canada Complex Percutaneous Coronary Intervention Market

        • 6.2.6.1. Market Size and Forecast, By Stents
        • 6.2.6.2. Market Size and Forecast, By Surgery

      • 6.2.7. Mexico Complex Percutaneous Coronary Intervention Market

        • 6.2.7.1. Market Size and Forecast, By Stents
        • 6.2.7.2. Market Size and Forecast, By Surgery

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Stents

      • 6.3.3. Market Size and Forecast, By Surgery

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Complex Percutaneous Coronary Intervention Market

        • 6.3.5.1. Market Size and Forecast, By Stents
        • 6.3.5.2. Market Size and Forecast, By Surgery

      • 6.3.6. Germany Complex Percutaneous Coronary Intervention Market

        • 6.3.6.1. Market Size and Forecast, By Stents
        • 6.3.6.2. Market Size and Forecast, By Surgery

      • 6.3.7. Italy Complex Percutaneous Coronary Intervention Market

        • 6.3.7.1. Market Size and Forecast, By Stents
        • 6.3.7.2. Market Size and Forecast, By Surgery

      • 6.3.8. Spain Complex Percutaneous Coronary Intervention Market

        • 6.3.8.1. Market Size and Forecast, By Stents
        • 6.3.8.2. Market Size and Forecast, By Surgery

      • 6.3.9. UK Complex Percutaneous Coronary Intervention Market

        • 6.3.9.1. Market Size and Forecast, By Stents
        • 6.3.9.2. Market Size and Forecast, By Surgery

      • 6.3.10. Russia Complex Percutaneous Coronary Intervention Market

        • 6.3.10.1. Market Size and Forecast, By Stents
        • 6.3.10.2. Market Size and Forecast, By Surgery

      • 6.3.11. Rest Of Europe Complex Percutaneous Coronary Intervention Market

        • 6.3.11.1. Market Size and Forecast, By Stents
        • 6.3.11.2. Market Size and Forecast, By Surgery

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Stents

      • 6.4.3. Market Size and Forecast, By Surgery

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Complex Percutaneous Coronary Intervention Market

        • 6.4.5.1. Market Size and Forecast, By Stents
        • 6.4.5.2. Market Size and Forecast, By Surgery

      • 6.4.6. Japan Complex Percutaneous Coronary Intervention Market

        • 6.4.6.1. Market Size and Forecast, By Stents
        • 6.4.6.2. Market Size and Forecast, By Surgery

      • 6.4.7. India Complex Percutaneous Coronary Intervention Market

        • 6.4.7.1. Market Size and Forecast, By Stents
        • 6.4.7.2. Market Size and Forecast, By Surgery

      • 6.4.8. South Korea Complex Percutaneous Coronary Intervention Market

        • 6.4.8.1. Market Size and Forecast, By Stents
        • 6.4.8.2. Market Size and Forecast, By Surgery

      • 6.4.9. Australia Complex Percutaneous Coronary Intervention Market

        • 6.4.9.1. Market Size and Forecast, By Stents
        • 6.4.9.2. Market Size and Forecast, By Surgery

      • 6.4.10. Thailand Complex Percutaneous Coronary Intervention Market

        • 6.4.10.1. Market Size and Forecast, By Stents
        • 6.4.10.2. Market Size and Forecast, By Surgery

      • 6.4.11. Malaysia Complex Percutaneous Coronary Intervention Market

        • 6.4.11.1. Market Size and Forecast, By Stents
        • 6.4.11.2. Market Size and Forecast, By Surgery

      • 6.4.12. Indonesia Complex Percutaneous Coronary Intervention Market

        • 6.4.12.1. Market Size and Forecast, By Stents
        • 6.4.12.2. Market Size and Forecast, By Surgery

      • 6.4.13. Rest of Asia Pacific Complex Percutaneous Coronary Intervention Market

        • 6.4.13.1. Market Size and Forecast, By Stents
        • 6.4.13.2. Market Size and Forecast, By Surgery

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Stents

      • 6.5.3. Market Size and Forecast, By Surgery

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Complex Percutaneous Coronary Intervention Market

        • 6.5.5.1. Market Size and Forecast, By Stents
        • 6.5.5.2. Market Size and Forecast, By Surgery

      • 6.5.6. South Africa Complex Percutaneous Coronary Intervention Market

        • 6.5.6.1. Market Size and Forecast, By Stents
        • 6.5.6.2. Market Size and Forecast, By Surgery

      • 6.5.7. Saudi Arabia Complex Percutaneous Coronary Intervention Market

        • 6.5.7.1. Market Size and Forecast, By Stents
        • 6.5.7.2. Market Size and Forecast, By Surgery

      • 6.5.8. UAE Complex Percutaneous Coronary Intervention Market

        • 6.5.8.1. Market Size and Forecast, By Stents
        • 6.5.8.2. Market Size and Forecast, By Surgery

      • 6.5.9. Argentina Complex Percutaneous Coronary Intervention Market

        • 6.5.9.1. Market Size and Forecast, By Stents
        • 6.5.9.2. Market Size and Forecast, By Surgery

      • 6.5.10. Rest of LAMEA Complex Percutaneous Coronary Intervention Market

        • 6.5.10.1. Market Size and Forecast, By Stents
        • 6.5.10.2. Market Size and Forecast, By Surgery

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Abbott Laboratories

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Medtronic Plc,

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Boston Scientific Corporation

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. B. Braun Melsungen AG

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Biosensors International Group, Ltd.,

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Biotronik SE And Co. KG,

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Terumo Corporation,

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Johnson And Johnson,

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Getinge AB,

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. St. Jude Medical.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR DRUG-ELUTING STENTS (DES), BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR BARE METAL STENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR BIORESORBABLE STENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR PERCUTANEOUS CORONARY INTERVENTION (PCI), BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI/TAVR), BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR TRANS-MITRAL VALVE IMPLANTATION (TMVR), BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. NORTH AMERICA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 13. U.S. COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 14. U.S. COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 15. CANADA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 16. CANADA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 17. MEXICO COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 18. MEXICO COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 19. EUROPE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 21. EUROPE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 22. FRANCE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 23. FRANCE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 24. GERMANY COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 25. GERMANY COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 26. ITALY COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 27. ITALY COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 28. SPAIN COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 29. SPAIN COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 30. UK COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 31. UK COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 32. RUSSIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 33. RUSSIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 34. REST OF EUROPE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 35. REST OF EUROPE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 36. ASIA-PACIFIC COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 37. ASIA-PACIFIC COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 38. ASIA-PACIFIC COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 39. CHINA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 40. CHINA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 41. JAPAN COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 42. JAPAN COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 43. INDIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 44. INDIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 45. SOUTH KOREA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 46. SOUTH KOREA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 47. AUSTRALIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 48. AUSTRALIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 49. THAILAND COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 50. THAILAND COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 51. MALAYSIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 52. MALAYSIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 53. INDONESIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 54. INDONESIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 57. LAMEA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 58. LAMEA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 59. LAMEA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 60. BRAZIL COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 61. BRAZIL COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 62. SOUTH AFRICA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 63. SOUTH AFRICA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 64. SAUDI ARABIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 65. SAUDI ARABIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 66. UAE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 67. UAE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 68. ARGENTINA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 69. ARGENTINA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 70. REST OF LAMEA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2022-2032 ($MILLION)
  • TABLE 71. REST OF LAMEA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 72. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 73. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 74. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 75. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 76. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 77. MEDTRONIC PLC,: KEY EXECUTIVES
  • TABLE 78. MEDTRONIC PLC,: COMPANY SNAPSHOT
  • TABLE 79. MEDTRONIC PLC,: OPERATING SEGMENTS
  • TABLE 80. MEDTRONIC PLC,: PRODUCT PORTFOLIO
  • TABLE 81. MEDTRONIC PLC,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 82. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 83. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 84. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 85. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 86. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 87. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 88. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 89. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 90. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 91. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 92. BIOSENSORS INTERNATIONAL GROUP, LTD.,: KEY EXECUTIVES
  • TABLE 93. BIOSENSORS INTERNATIONAL GROUP, LTD.,: COMPANY SNAPSHOT
  • TABLE 94. BIOSENSORS INTERNATIONAL GROUP, LTD.,: OPERATING SEGMENTS
  • TABLE 95. BIOSENSORS INTERNATIONAL GROUP, LTD.,: PRODUCT PORTFOLIO
  • TABLE 96. BIOSENSORS INTERNATIONAL GROUP, LTD.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 97. BIOTRONIK SE AND CO. KG,: KEY EXECUTIVES
  • TABLE 98. BIOTRONIK SE AND CO. KG,: COMPANY SNAPSHOT
  • TABLE 99. BIOTRONIK SE AND CO. KG,: OPERATING SEGMENTS
  • TABLE 100. BIOTRONIK SE AND CO. KG,: PRODUCT PORTFOLIO
  • TABLE 101. BIOTRONIK SE AND CO. KG,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 102. TERUMO CORPORATION,: KEY EXECUTIVES
  • TABLE 103. TERUMO CORPORATION,: COMPANY SNAPSHOT
  • TABLE 104. TERUMO CORPORATION,: OPERATING SEGMENTS
  • TABLE 105. TERUMO CORPORATION,: PRODUCT PORTFOLIO
  • TABLE 106. TERUMO CORPORATION,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. JOHNSON AND JOHNSON,: KEY EXECUTIVES
  • TABLE 108. JOHNSON AND JOHNSON,: COMPANY SNAPSHOT
  • TABLE 109. JOHNSON AND JOHNSON,: OPERATING SEGMENTS
  • TABLE 110. JOHNSON AND JOHNSON,: PRODUCT PORTFOLIO
  • TABLE 111. JOHNSON AND JOHNSON,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. GETINGE AB,: KEY EXECUTIVES
  • TABLE 113. GETINGE AB,: COMPANY SNAPSHOT
  • TABLE 114. GETINGE AB,: OPERATING SEGMENTS
  • TABLE 115. GETINGE AB,: PRODUCT PORTFOLIO
  • TABLE 116. GETINGE AB,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. ST. JUDE MEDICAL.: KEY EXECUTIVES
  • TABLE 118. ST. JUDE MEDICAL.: COMPANY SNAPSHOT
  • TABLE 119. ST. JUDE MEDICAL.: OPERATING SEGMENTS
  • TABLE 120. ST. JUDE MEDICAL.: PRODUCT PORTFOLIO
  • TABLE 121. ST. JUDE MEDICAL.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET SEGMENTATION
  • FIGURE 2. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 3. SEGMENTATION COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCOMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 11. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET SEGMENTATION, BY BY STENTS
  • FIGURE 12. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR DRUG-ELUTING STENTS (DES), BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR BARE METAL STENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR BIORESORBABLE STENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET SEGMENTATION, BY BY SURGERY
  • FIGURE 16. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR PERCUTANEOUS CORONARY INTERVENTION (PCI), BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI/TAVR), BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR TRANS-MITRAL VALVE IMPLANTATION (TMVR), BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 20. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 21. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 22. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 23. COMPETITIVE DASHBOARD
  • FIGURE 24. COMPETITIVE HEATMAP: COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 25. Top player positioning, 2022
  • FIGURE 26. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 27. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 28. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 29. MEDTRONIC PLC,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 30. MEDTRONIC PLC,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 31. MEDTRONIC PLC,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 32. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 33. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 34. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 35. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. BIOSENSORS INTERNATIONAL GROUP, LTD.,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. BIOSENSORS INTERNATIONAL GROUP, LTD.,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. BIOSENSORS INTERNATIONAL GROUP, LTD.,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. BIOTRONIK SE AND CO. KG,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. BIOTRONIK SE AND CO. KG,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. BIOTRONIK SE AND CO. KG,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. TERUMO CORPORATION,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. TERUMO CORPORATION,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. TERUMO CORPORATION,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. JOHNSON AND JOHNSON,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. JOHNSON AND JOHNSON,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. JOHNSON AND JOHNSON,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. GETINGE AB,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. GETINGE AB,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. GETINGE AB,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. ST. JUDE MEDICAL.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. ST. JUDE MEDICAL.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. ST. JUDE MEDICAL.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Complex Percutaneous Coronary Intervention Market

Start reading.
This Report and over 67,069+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers